Gene therapies have seen a drop in investor interest lately. Despite this, Kriya Therapeutics seems to be attracting funds in ...

Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin ...

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...

As the release of a CRL declining Lykos' therapy generates a strong reaction from MAPS, delve into what this new transparency ...

Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.